Misra Vatsala, Agrawal Ranjan, Kumar Harendra, Kar Asaranti, Kini Usha, Poojary Aruna, Chakrabarti Indranil, Rai Sharada, Singhal Anika, Shankar S Vijay, Iyengar Jayaram N
Pathology, MLN Medical College, Prayagraj, Uttar Pradesh, India.
Pathology, Rohilkhand Medical College and Hospital, Bareilly, Uttar Pradesh, India.
Indian J Pathol Microbiol. 2020 Jul-Sep;63(3):350-357. doi: 10.4103/IJPM.IJPM_857_20.
Declared as a pandemic by WHO on March 11, 2020, COVID-19 has brought about a dramatic change in the working of different laboratories across the country. Diagnostic laboratories testing different types of samples play a vital role in the treatment management. Irrespective of their size, each laboratory has to follow strict biosafety guidelines. Different sections of the laboratory receive samples that are variably infectious. Each sample needs to undergo a proper and well-designed processing system so that the personnel involved are not infected and also their close contacts. It takes a huge effort so as to limit the risk of exposure of the working staff during the collection, processing, reporting or dispatching of biohazard samples. Guidelines help in preventing the laboratory staff and healthcare workers from contracting the disease which has a known human to human route of transmission and high rate of mortality. A well-knit approach is the need of the hour to combat this fast spreading disease. We anticipate that the guidelines described in this article will be useful for continuing safe work practices by all the laboratories in the country.
2020年3月11日,世界卫生组织宣布新型冠状病毒肺炎(COVID-19)为大流行病,这给全国不同实验室的工作带来了巨大变化。检测不同类型样本的诊断实验室在治疗管理中发挥着至关重要的作用。无论规模大小,每个实验室都必须遵循严格的生物安全准则。实验室的不同区域会接收具有不同传染性的样本。每个样本都需要经过适当且精心设计的处理系统,以确保相关人员及其密切接触者不被感染。为了在生物危害样本的采集、处理、报告或分发过程中降低工作人员的暴露风险,需要付出巨大努力。这些准则有助于防止实验室工作人员和医护人员感染这种已知具有人际传播途径且死亡率高的疾病。当前迫切需要一种紧密结合的方法来对抗这种快速传播的疾病。我们预计本文所述的准则将有助于全国所有实验室继续实施安全的工作流程。